On March 27th, 2019, the Secretary of Health through the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) revoked the “Guidelines on health control of cannabis and derivatives thereof” that were published on October 30th, 2018.
These guidelines were used as a basis for issuing 57 import licenses for cannabis products. The first 38 of the 57 received headlines as being the first registered cannabis products in Mexico. Now, due to the revocation of the guidelines released under the former government, current authorities are reviewing the validity of the “supposed authorizations.”
The COFEPRIS declared that the guidelines “contravene the framework of what was mandated in the Decree by which the General Health Law was reformed in 2017, for having exceeded its purpose by authorizing the commercialization of various products with cannabis derivative”.
In addition to this, the COFEPRIS said they decided to revoke the previous guidelines because they fail to comply with customs tariff regulations, were not published in the Official Journal of the Federation, and were not presented to the Regulatory Burden Reduction Program.
Now, the 57 authorized products are officially under review and the permits are called into question. Thus far, few of them have actually been imported into Mexico, as one week after the “authorizations” were granted they were already being publicly challenged by Mexico’s president of the foreign trade commission.